Trial Profile
An Evaluation of the Pharmacokinetic Linearity and Comparative Bioavailability of a Single Oral Dose of 0.5 mg, 1 mg and 2.5 mg UT-15C (Treprostinil Diethanolamine) SR Tablets in Healthy Volunteers in the Fed State
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Peripheral ischaemia; Pulmonary arterial hypertension
- Focus Pharmacokinetics
- Sponsors United Therapeutics Corporation
- 12 Aug 2014 New trial record
- 20 Aug 2010
- 12 Jul 2010